Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
Saved in:
| Title: | Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis. |
|---|---|
| Authors: | Yang, Shuo1 (AUTHOR), Hou, Yibing2 (AUTHOR), Wang, Xiaohui3 (AUTHOR), Kang, Shuo4 (AUTHOR) shuok628@hebmu.edu.cn, Pan, Zhenhua3 (AUTHOR) panzhenhua@hebmu.edu.cn |
| Source: | PLoS ONE. 6/11/2026, Vol. 21 Issue 6, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0351029 |
